tirzepatide vs glp-1 Major physiological roles of and GIP. is acting as an GLP-1 Medications for Weight Loss:

The best plan is often multimodal rather than medication-only

Tirzepatide (Mounjaro, Eli Lilly), has not been recommended in draft guidance issued by NICE on 27 June for treating type 2 diabetes in adults alongside diet and exercise

Health coaching is included in the Goodweigh weight loss program at no extra cost

E., Gurpide, E., Liu, R., & Anderson, K

The participants in the 5:2 meal replacement group consumed one serving of a low-energy product instead of all three regular meals for two nonconsecutive days

National Transformation Program (2020) Accessed from: Accessed 29 Jan 2025 Nauck MA, DAlessio DA (2022) Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction